Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Fanni Segev"'
Autor:
Noa Chetrit, Pnina Fishman, William D Kerns, Kenneth A. Jacobson, Irina S. Barequet, Motti Farbstein, Sara Bar Yehuda, Hanna J. Garzozi, Gil Sartani, Michael H. Silverman, Gilad Litvin, Erez Bakshi, Oren Tomkins, David Zadok, Ilan Cohn, Zivit Harpaz, Fanni Segev, David Bristol, Sari Fishman, David Varssano, Isaac Avni
Publikováno v:
Ophthalmology. 117:1287-1293
Objective To explore the safety and efficacy of CF101, an A 3 adenosine receptor agonist, in patients with moderate to severe dry eye syndrome. Design Phase 2, multicenter, randomized, double-masked, placebo-controlled, parallel-group study. Particip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::892ce353f39cb2ceabc184845b3441f6
https://doi.org/10.1016/j.ophtha.2009.11.029
https://doi.org/10.1016/j.ophtha.2009.11.029
Autor:
Isaac, Avni, Hanna J, Garzozi, Irina S, Barequet, Fanni, Segev, David, Varssano, Gil, Sartani, Noa, Chetrit, Erez, Bakshi, David, Zadok, Oren, Tomkins, Gilad, Litvin, Kenneth A, Jacobson, Sari, Fishman, Zivit, Harpaz, Motti, Farbstein, Sara Bar, Yehuda, Michael H, Silverman, William D, Kerns, David R, Bristol, Ilan, Cohn, Pnina, Fishman
To explore the safety and efficacy of CF101, an A(3) adenosine receptor agonist, in patients with moderate to severe dry eye syndrome.Phase 2, multicenter, randomized, double-masked, placebo-controlled, parallel-group study.Sixty-eight patients compl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::9d5658962bd6a6636faf5f51c38010f3
https://europepmc.org/articles/PMC3668568/
https://europepmc.org/articles/PMC3668568/
